Insight Molecular Diagnostics, Inc. (IMDX)
5.95
-0.46
(-7.18%)
USD |
NASDAQ |
May 18, 12:11
Insight Molecular Diagnostics Shareholders Equity (Quarterly) : -10.69M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Veracyte, Inc. | 1.344B |
| Exagen, Inc. | 14.43M |
| bioAffinity Technologies, Inc. | 3.661M |
| GRAIL, Inc. | 2.501B |
| FONAR Corp. | 178.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.43M |
| Total Liabilities (Quarterly) | 51.12M |
| Debt to Equity Ratio | -0.2871 |
| Current Ratio | 2.542 |
| Net Debt Paydown Yield | 0.11% |